CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-11-16 | LEVIN MARK J Director | Conversion · Series A Preferred Stock | −45,000,000 | 0 | ||
| 2015-11-16 | Sanofi Former 10% owner | Purchase | +125,000 | $14.00 | $1.8M | 2,477,941 |
| 2015-11-16 | Third Rock Ventures III, L.P. 10% owner | Conversion | +10,588,235 | 11,061,176 | ||
| 2015-11-16 | Third Rock Ventures III, L.P. 10% owner | Conversion · Series A Preferred Stock | −45,000,000 | 0 | ||
| 2015-11-16 | Hadley Harbor Master Investors (Cayman) L.P. 10% owner | Conversion | +470,588 | 470,588 | ||
| 2015-11-16 | Hadley Harbor Master Investors (Cayman) L.P. 10% owner | Conversion · Series B Convertible Preferred Stock | −2,000,000 | 0 | ||
| 2015-11-10 | Sanofi Former 10% owner | Conversion | +2,352,941 | 2,352,941 | ||
| 2015-11-10 | Sanofi Former 10% owner | Conversion · Shares of Series B convertible preferred stock | −10,000,000 | 0 |
Page 19 of 19 · 368 trades